Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GluStitch Inc. is a Canadian medical device company based in Delta, British Columbia, that specializes in the development and manufacture of high-purity, medical-grade cyanoacrylate tissue adhesives. Established in 2003, the company provides a versatile portfolio of products designed for non-invasive wound management, including its flagship GluStitch® topical adhesive and PeriAcryl® for oral and dental applications. Their technology utilizes proprietary blends of n-butyl and 2-octyl cyanoacrylates to balance adhesive strength with clinical flexibility, effectively replacing or supplementing traditional sutures. GluStitch maintains rigorous quality standards with ISO 13485 certification and holds regulatory clearances including FDA 510(k) and CE marking. The company's solutions are widely used across human medicine, dentistry, and veterinary care through a global network of authorized distributors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GluStitch.